About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis

NCT00995449·11 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Humanigen, Inc.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

At least 6 swollen and at least 6 tender joints
C-reactive Protein (CRP) \> Upper Limit Normal (ULN)
Prior inadequate response from biologic therapy
Stable regimens of concomitant RA therapies

You may not be if

Unstable medical conditions

The record

StatusTerminated

PhasePhase 2

Taking part9

StartedJan 2010

UpdatedJun 9, 2014

Conditions

Rheumatoid Arthritis

Where11

Stanford, California, United States
Westlake Village, California, United States
Miami, Florida, United States

Clareo Health | Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis